Our Pricing

Omeprazole vs Lansoprazole UK Comparison

Published on: June 03, 2026

When comparing omeprazole vs lansoprazole UK options, both proton pump inhibitors (PPIs) effectively reduce stomach acid, but subtle differences in onset time, duration, and tolerability may influence which suits you best. At Cured Pharmacy, our UK-registered clinical team helps patients navigate PPI choices with transparent pricing from £9.99 and free online consultations completed in under three minutes.

How Omeprazole and Lansoprazole Work

Both omeprazole and lansoprazole belong to the proton pump inhibitor class, blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells to suppress acid production [1]. This mechanism provides sustained relief from gastro-oesophageal reflux disease (GORD), peptic ulcers, and dyspepsia by maintaining gastric pH above 4 for extended periods.

Clinical studies demonstrate that lansoprazole achieves peak plasma concentration slightly faster than omeprazole—approximately 1.7 hours versus 2 hours—though both medications require 2-3 days of consistent dosing to reach full acid-suppressing effect [2]. The MHRA has licensed both PPIs for short-term treatment of reflux symptoms and long-term management of erosive oesophagitis when prescribed by a UK clinician.

Omeprazole vs Lansoprazole: Efficacy Comparison

Head-to-head trials show comparable healing rates for erosive oesophagitis, with omeprazole 20mg and lansoprazole 30mg achieving approximately 80-85% healing at 8 weeks [1][3]. However, lansoprazole demonstrates marginally faster symptom relief in the first 48 hours due to its quicker absorption profile, making it preferable for patients seeking rapid heartburn control.

For maintenance therapy, both medications prevent relapse effectively. A 12-month comparative study found omeprazole 20mg and lansoprazole 30mg maintained remission in 73% and 77% of patients respectively—a difference not reaching statistical significance [3]. Your UK prescriber will consider symptom severity, previous PPI response, and concurrent medications when recommending the optimal choice.

Dosing Considerations

Standard dosing differs between the two PPIs: omeprazole is typically prescribed at 20mg once daily, whilst lansoprazole uses 30mg once daily for equivalent acid suppression [2]. Both are available in lower maintenance doses—omeprazole 10mg and lansoprazole 15mg—for long-term symptom control after initial healing. Cured Pharmacy stocks both strengths, with omeprazole capsules starting from £9.99 and lansoprazole from £9.99, subject to prescriber approval.

Side Effects and Tolerability Profile

Both PPIs share similar adverse effect profiles, with headache (occurring in 2-7% of patients), nausea, diarrhoea, and abdominal pain being most commonly reported [1][4]. Long-term use beyond 12 months carries potential risks including vitamin B12 deficiency, hypomagnesaemia, and increased fracture risk—concerns applicable to all proton pump inhibitors rather than specific to either medication.

Some patients report better tolerability with one PPI over another due to individual metabolic differences. Lansoprazole's formulation as gastro-resistant capsules may suit those with swallowing difficulties, whilst omeprazole is available in both capsule and tablet forms. If you experience persistent side effects with one PPI, switching to the alternative under clinical guidance often resolves tolerability issues without compromising efficacy.

Drug Interactions and Contraindications

Omeprazole exhibits more significant cytochrome P450 interactions than lansoprazole, particularly affecting CYP2C19 substrates like clopidogrel, warfarin, and certain antifungals [4]. The MHRA advises caution when co-prescribing omeprazole with clopidogrel due to reduced antiplatelet efficacy—lansoprazole presents a safer alternative in patients requiring dual therapy.

Both PPIs reduce stomach acidity, potentially affecting absorption of pH-dependent medications including ketoconazole, itraconazole, and erlotinib. Your UK prescriber will review your complete medication list during the online consultation to identify potential interactions and recommend the most appropriate PPI. Neither medication should be used in patients with known hypersensitivity to benzimidazole compounds.

Special Populations

Pregnant and breastfeeding women require individualised assessment, though omeprazole has more extensive safety data in pregnancy and is generally preferred when PPI therapy proves essential [4]. Elderly patients metabolise both medications similarly and rarely require dose adjustment unless severe hepatic impairment exists. Renal function does not significantly affect either PPI, making them suitable across most patient populations subject to prescriber evaluation.

Cost and Accessibility at UK Pharmacies

Generic omeprazole represents the most cost-effective PPI option, with prices at Cured Pharmacy starting from £9.99 for a month's supply of 10mg or 20mg capsules. Lansoprazole costs slightly more at £9.99, reflecting manufacturing differences rather than superior efficacy. Both medications require a valid UK prescription obtained through our free online consultation service.

Brand-name alternatives like Losec (omeprazole) and Zoton FasTab (lansoprazole) cost considerably more—£9.99 and £9.99 respectively—without offering additional therapeutic benefit over generic versions. Our superintendent pharmacist Tarun Kumar ensures all dispensed medications meet MHRA quality standards regardless of price point, providing genuine UK-licensed medicines with complete regulatory compliance.

Choosing Between Omeprazole and Lansoprazole

For most patients, omeprazole serves as the first-line PPI due to extensive clinical experience, lower cost, and proven efficacy across all licensed indications. Lansoprazole may be preferable if you need faster initial symptom relief, take medications with significant omeprazole interactions (particularly clopidogrel), or previously experienced tolerability issues with omeprazole.

The decision ultimately rests on individual clinical factors assessed during your consultation with a UK prescriber. Both PPIs achieve comparable outcomes in clinical trials, and switching between them often proves successful if initial therapy doesn't meet expectations [3]. Cured Pharmacy's transparent pricing and comprehensive product range—including esomeprazole and pantoprazole alternatives—ensures you receive the optimal PPI for your specific needs.

Starting Your PPI Treatment

Complete our free online consultation in under three minutes to receive a clinical assessment from UK-registered prescribers. If appropriate, your chosen PPI will be dispensed from our GPhC-registered pharmacy (9012511) with discreet next-day delivery across the UK. All prescription medications require prescriber approval, and our clinical team remains available at (+44) 116 4646009 for any questions about your acid reflux treatment.

Scientific References

1. Stedman, C. A., & Barclay, M. L. (2000). Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963-978. https://doi.org/10.1046/j.1365-2036.2000.00788.x [accessed 13 August 2026]
2. Andersson, T., Hassan-Alin, M., Hasselgren, G., Röhss, K., & Weidolf, L. (2001). Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole. Clinical Pharmacokinetics, 40(6), 411-426. https://doi.org/10.2165/00003088-200140060-00003 [accessed 13 August 2026]
3. Dekkers, C. P., Beker, J. A., Thjodleifsson, B., Gabryelewicz, A., Bell, N. E., & Humphries, T. J. (1999). Double-blind comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics, 13(1), 49-57. https://doi.org/10.1046/j.1365-2036.1999.00430.x [accessed 13 August 2026]
4. Wedemeyer, R. S., & Blume, H. (2014). Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update. Drug Safety, 37(4), 201-211. https://doi.org/10.1007/s40264-014-0144-0 [accessed 13 August 2026]
5. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.